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Abstraet--Cyclosporin A (CsA) has been reported to inhibit phorbol myristate acetate (PMA)-induced 
superoxide anion (02) formation in human eutrophils and murine macrophages. We found that CsA 
inhibited 02 formation in HL-60 cells induced by PMA (30 nM) and phorbol dibutyrate (200 nM) with 
a half-maximal effect at 1 and 0.75 pM, respectively. One possible target of CsA action is protein kinase 
C (PKC) [EC 2.7.1.37] since phorbol esters activate this kinase. However, CsA did not inhibit PMA- 
mediated reduction of histamine-induced rises in cytosolic Ca 2+ concentration i , and PMA-induced 
differentiation of, HL-60 cells and platelet aggregation. CsA did not reduce the activity of various 
recombinant c-PKC isoenzymes (o~,/31 and 7), n-PKC isoenzymes (6and e), an a-PKC isoenzyme (~) 
nor of PKC purified from rat brain in vitro. These data show that CsA inhibits phorbol ester-induced 
O2 formation in HL-60 cells but not other phorbol ester-mediated vents and that inhibition by CsA 
of O2 formation cannot readily be attributed to direct PKC inhibition. We also show that CsA does 
not change the activity of nucleoside diphosphate kinase ]EC 2.7.4.6] in HL-60 membranes nor the 
latter's physical properties. 
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Phagocytes possess a multi-component NADPH 
oxidase [EC 1.6.99.6] which catalyses the formation 
of o~11, NADPH being the electron donor [1-3]. 
Among the regulatory components of NADPH 
oxidase are small GTP-binding proteins and NDPK 
[EC 2.7.4.6] [1-3]. O~- formation can be stimulated 
by formyl peptides and PMA [1-3]. PKC [EC 
2.7.1.37] plays a crucial role in NADPH oxidase 
activation [1-3]. PKC is a family comprising c-, n- 
and a-PKC isoenzymes [4-6]. c-PKC isoenzymes (or, 
ill,/32 and y) are Ca2+-dependent a d are activated 
by PMA. n-PKC isoenzymes (6, e, r/ and 0) are 
activated by phorbol esters as well but are Ca 2÷- 
independent. A third group of PKC isoenzymes, a-
PKC (~ and ~.), is not substantially activated by 
phorbol esters and is also Ca2+-independent. Recent 
data indicate that n-PKC isoenzymes are involved 
in PMA- and formyl peptide-induced activation of 
OF formation [7]. 
The immunosuppressant, CsA [8], inhibits PMA- 
induced Or formation in murine peritoneal macro- 
phages and human neutrophils [9-11]. In addition, 
CsA inhibits formyl peptide-induced OF formation 
in neutrophils and HL-60 cells [10-12]. The precise 
mechanism by which these effects are accomplished 
is poorly understood. With regard to c-PKC 
isoenzymes, both inhibitory effects and the lack of 
effect of CsA on enzyme activity have been reported 
[13, 14]. The aim of the present study was to learn 
more about he mechanism underlying the inhibitory 
effect of CsA on Or formation, especially inasmuch 
as CsA is a direct inhibitor of n-PKC isoenzymes. 
MATERIALS AND METHODS 
~: Present address: Institut ffir Molekulare Medizin und 
Naturstofforschung, Klinik ffir Tumorbiologie, Brei- 
sacherstr. 117, D-79106 Freiburg, F.R.G. 
§ Corresponding author. Tel. (49) 30 838 2064; FAX 49 
30 831 5954. 
IIAbbreviations: ATP[yS], adenosine 5'-[y-thio]tri- 
phosphate; [Ca2+],, cytosolic Ca 2+ concentration; CsA, 
cyclosporin A; G6 6850, 2 - (1H- indol - 3 - yl) - 3 - [1 - (3 - 
dimethylaminopropyl)- 1H-indol-3-yl]- maleinimide; GO 
6976, 12- (2- cyanoethyl)- 6,7,12,13- tetrahydro- 13- methyl 
- 5 - oxo - 5H - indolo[2, 3 - a]pyrrolo[3, 4 - c] - carbazole; 
GTP[TS], guanosine 5'-[7-thio]triphosphate; NDPK, 
nucleoside diphosphate kinase; 02, superoxide anion; 
PDB, phorbol dibutyrate; PKC, protein kinase C; PMA, 
phorbol myristate acetate. 
Materials. CsA was kindly provided by Sandoz 
(Basel, Switzerland). A stock solution of CsA 
( lmM) was prepared in 100% (v/v) dimethyl 
sulfoxide and stored in polypropylene tubes at -20 ° 
under light protection for up to 4 weeks. The final 
dimethyl sulfoxide concentration in assays was 
adjusted to 0.3% (v/v). PMA and PDB were 
obtained from Sigma Chemie (Deisenhofen, 
F.R.G.). [SerineZS]PKC(19-31) was obtained from 
Peninsula (Belmont, CA, U.S.A.). G6 6850 and G6 
6976 were provided by G6decke AG (Freiburg, 
F. R.G.). [y-32p]ATP (3 Ci/mmol) was obtained from 
Amersham (Braunschweig, F.R.G.). Sources of 
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other materials have been described elsewhere 
[7, 10, 12, 15-21}. 
Cell culture. HL-60 cells were cultured in 
suspension culture at 37 ° and differentiated towards 
neutrophil-like c lls upon incubation with dibutyryl 
cAMP (0.2 mM) for 48 hr [15]. In other experiments, 
HL-60 cells were differentiated towards macrophage- 
like cells with PMA (10-100 nM) for 96 hr [22]. 
Assay for 0~ formation in HL-60 cells. 02 
formation was monitored at 550 nm by continuous 
measurement of ferricytochrome C reduction 
inhibitable by superoxide dismutase, using an Uvikon 
810 dual beam spectrophotometer (Kontron, Eching, 
F.R.G.) [15]. Reaction mixtures (0.5 mL) contained 
100/~M ferricytochrome C and a buffer consisting of 
138mM NaC1, 6mM KC1, 1 mM MgCI2, 1 mM 
CaC12, 5.5 mM glucose and 20 mM Hepes/NaOH, 
pH 7.4. HL-60 cells (2.5 x 106 cells/cuvette) were 
suspended in the solution described above and 
incubated for 3 min in the presence of solvent 
(control) or various concentrations of CSA at 37 °. 
O~- formation was initiated by the addition of stimuli. 
The maximum rates of O~- formation were calculated. 
Measurement of [Ca2+]i. [Ca2+]i was determined 
using the fluorescent dye, Fura-2, as described 
previously [16]. Fluorescence of HL-60 cells 
(1.0 × 106 cells in 2 mL) was determined at37 ° under 
constant stirring at 103 rpm using a Ratio II 
spectrofluorometer (Aminco, Silver Spring, MD, 
U.S.A.). Cells were incubated for 3min in the 
absence or presence of CsA before the addition of 
solvent (control) or PMA. After an additional 3 min, 
stimulus was added to the cells. 
Platelet aggregation. Isolation of platelets from 
healthy drug-free volunteers was performed as 
described previously [17]. Platelet aggregation was 
studied in an Aggrecorder II PA-3220 (Kyoto Daiichi 
Kagaku, Kyoto, Japan) according to Berg et al. [17]. 
Solvent (control) or CsA was added to platelets 
3 min before the addition of stimuli. 
Preparation of recombinant PKC isoenzymes and 
purification of PKC from rat brain. Full-length 
human cDNAs for PKC isoenzymes o4 /31, and ~, 
rat cDNA for PKC isoenzyme 7 and mouse cDNAs 
for PKC isoenzymes 6 and e were inserted into the 
baculovirus expression vector, pVL1393 [18,23]. 
Expression of PKC isoenzymes in Sf9 insect 
cells and purification of expressed enzymes were 
performed as described elsewhere [18]. PKC from 
rat brain was prepared according to the procedure 
described by Inagaki et al.[24]. This purification 
resulted in a mixed preparation of the four c-PKC 
isoenzymes as revealed by immunoblotting with 
isoenzyme-specific antibodies (data not shown). 
Determination of PKC activity. For determination 
of PKC activity, reaction mixtures (200/~L) contained 
5-10 units of PKC (1 unit transfers lpmol  of 
phosphate/min), 10/~M [7-32p]ATP (0.2/~Ci/tube), 
40/~g of histone H~, 5 mM MgC12, 1 mM EDTA, 
1.25mM EGTA, 1.32mM CaCI2, lmM dithio- 
threitol, lktg of phosphatidylserine and 0.2#g of 
diolein in 50 mM Hepes/NaOH, pH 7.5. Reaction 
mixtures additionally contained solvent (control), 
CsA or G6 6850. Reactions were initiated by the 
addition of [y-32p]ATP and conducted for 5 min at 
30 ° . Reactions were terminated by the addition of 
2mL of 8.5% (w/v) H3PO 4 and filtration through 
0.45/~m Sartorius nitrocellulose filters. Radioactivity 
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Fig. 1. Effect of CsA on PMA-induced O2 formation in HL-60 cells. O2 formation was determined as 
described in Materials and Methods. (A) Concentration-response curve to PMA. CsA (1 ~tM) (0) or 
solvent (control) (11) was added to reaction mixtures 3min before the addition of PMA at the indicated 
concentrations. (B) Concentration-response curve to CsA. CsA was added to reaction mixtures 3rain 
before the addition of PMA (30 nM). 02 formation in the presence of solvent (control) amounted to 
3.64 _+ 0.21 nmol/min per 106 cells. Data shown are the means of four experiments carried out with 
different preparations of HL-60 cells. The SD values of the data were generally <10% of the means. 
Inhibition of superoxide anion 
bound to filters was determined in a liquid scintillation 
spectrometer. Reaction mixtures for determination 
of PKC isoenzyme ~ activity contained 2 #g of 
[serine25]PKC(19-31) rather than histone H 1 as 
phosphate acceptor, and P81 Whatman phos- 
phocellulose filters were used instead of nitrocellulose 
filters [25]. As phospholipid-dependent activity of 
PKC isoenzyme ~ is very low [5, 18], the total 
incorporation of phosphate into [serine25]PKC(19 - 
31) was regarded as enzyme activity. 
Measurement of NDPK activity. GTP[yS] for- 
mation was determined as described previously 
[23]. Reaction mixtures (50#L) contained HL-60 
membranes (40 ~g of protein/tube), 0.5 ktM [3H]- 
GDP (1 #Ci/tube), 50 #M ATP[yS], 2 mM MgC12, 
0.1mM EGTA, l mM dithiothreitol and 0.2% 
(w/v) BSA in 50 mM triethanolamine/HCl, pH 7.4. 
Reaction mixtures additionally contained solvent 
(control) or CsA. Reactions were conducted for 
15 min at 25 °. Nucleotides were separated by TLC 
and eluted from TLC plates as described [19]. 
Steady-state and differential polarized phase 
fluorometry. Determination of steady-state and 
differential phase fluorescence of 1,6- 
diphenylhexa-l,3,5-triene-loaded HL-60 membranes 
was performed as described [20]. Membranes were 
incubated for 10 min at 25 ° in the presence of solvent 
(control) or CsA. Fluorescence measurements were 
performed at 25 ° in a SLM 4800 spectrofluorometer 
(SLM Instruments, Urbana, IL, U.S.A.) equipped 
with a thermostated cuvette holder. 
A TPase [EC 3.6.1.3] assays. Determination f the 
activities of Na+/K+-ATPase and Mg2+-ATPase in 
HL-60 membranes was performed as described by 
formation by cyclosporin A 861 
Ebel etal. [21]. Reaction mixtures (100 ~L) contained 
6.0 #g of protein and solvent (control) or CsA. The 
amount of inorganic phosphate in supernatant fluids 
of reaction mixtures was determined according to 
Ames [26]. 
Miscellaneous. Protein was determined according 
to Lowry et al. [27]. HL-60 membranes were 
prepared as described [19]. 
RESULTS 
We first studied the effects of CsA, G6 6850 and 
G6 6976 on phorbol ester-induced O~- formation in 
HL-60 cells. PMA activated Or formation with a 
half-maximal effect at 25 nM and a maximum effect 
at 100 nM (Fig. 1). When compared to PMA, PDB 
was similarly effective but about 10-fold less potent 
at activating O~ formation (Fig. 2). CsA (1 #M) 
inhibited Or formation induced by PMA and PDB 
at submaximally and maximally effective con- 
centrations of the stimuli. The inhibitory effect of 
CsA on Or formation induced by PMA (30 nM) was 
half-maximal t1 #M and was complete at 3 #M (see 
Fig. 1). With respect o Or formation induced by 
PDB (200nM), the inhibitory effect of CsA was 
half-maximal t 0.75 #M and maximal at 3 ~tM (see 
Fig. 2). G6 6850 (1 #M), an inhibitor of c- and n- 
PKC isoenzymes [18], abolished the stimulatory 
effects of PMA on Of formation, whereas G6 6976 
(1 pM), a selective inhibitor of c-PKC isoenzymes 
[18], was ineffective (data not shown). These data 
are in agreement with those obtained with human 
neutrophils and substantiate he view that n-PKC 
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Fig. 2. Effect of CsA on PDB-induced O£ formation in HL-60 cells. 02 formation was determined as 
described in Materials and Methods. (A) Concentration-response curve to PDB. CsA (1/~M) (O) or 
solvent (control) (11) was added to reaction mixtures 3min before the addition of PDB at the indicated 
concentrations. (B): Concentration-response curve to CsA. CsA was added to reaction mixtures 3min 
before the addition of PDB (200 nM). 02 formation in the presence of solvent (control) amounted to 
1.85 -+ 0.10 nmol/min per 10 6 cells. Data shown are the means of four experiments carried out with 
different preparations of HL-60 cells. The SD values of the data were generally <10% of the means. 
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Table 1. Effects of CsA and G0 6850 on the activity of 
recombinant PKC isoenzymes a, /31, y, 6, e and ~ and 
PKC purified from rat brain 
Enzyme 
Enzyme activity 
(% of control) 
CsA G6 6850 
PKC isoenzyme a 98 6 
PKC isoenzyme/31 100 18 
PKC isoenzyme 7 113 12 
PKC isoenzyme 6 104 2 
PKC isoenzyme ~- 108 0 
PKC isoenzyme ~ 104 ND 
PKC from rat brain (a,/31,/32, y) 100 3 
The activity of PKC was determined as described in 
Materials and Methods. Enzyme activity refers to that 
observed in the presence of solvent (control). CsA was 
employed at a concentration of 10gM throughout. In 
experiments with PKC isoenzymes ol, /31 and y and PKC 
purified from rat brain, G6 6850 was employed at a 
concentration of 300 nM, and in experiments with PKC 
isoenzymes e and & G6 6850 concentration was 10 ~M. 
Data shown are the means of two independent experiments 
performed in triplicate. The SD values of the data were 
generally <5% of the means. 
ND, not done. 
isoenzymes are involved in PMA-mediated activation 
of NADPH oxidase [7]. 
In addition to activation of O2 formation, 
PMA shows numerous other biological effects: e.g., 
inhibition of receptor agonist-induced rises in 
[Ca:+]i [16], induction of macrophage-like dif- 
ferentiation of HL-60 cells [22] and activation of 
platelet aggregation [28]. PMA (2 nM) abolished the 
stimulatory effect of histamine (100 ~M) on [Ca2+]i 
in HL-60 cells, but CsA (1/~M) could not revert his 
inhibition (data not shown). In addition, PMA (10- 
100 nM) induced macrophage-like differentiation of
HL-60 cells as assessed by adherence and changes 
in morphology. Again, CsA (1 gM) did not prevent 
the phorbol ester effect (data not shown). Moreover, 
PMA induced aggregation of human platelets with 
a half-maximal effect at 10 nM and a maximum at 
100nM, but CsA (1/~M) did not affect platelet 
aggregation i duced by PMA (data not shown). 
The effects of CsA on the activity of recombinant 
PKC isoenzymes oc, i l l , y, 6, e and _~ and on c-PKC 
isoenzymes purified from rat brain were studied in 
vitro (Table 1). CsA (1 and 10/IM, data for CsA at 
1/IM not shown) did not substantially reduce the 
activity of any of the PKC isoenzymes tudied. In 
addition, CsA (1 and 10/~M) did not affect the 
activity of PKC purified from rat brain. By contrast 
to CsA, G6 6850 strongly reduced the activity of c- 
and n-PKC isoenzymes and of PKC purified from 
rat brain (see Table 1). 
The effect of CsA on NDPK-catalysed GTP[yS] 
formation in HL-60 membranes was studied. NDPK 
catalysed the formation of 9.4---0.8pmoles of 
GTP[yS] from GDP and ATP[yS]/mg (mean +- SD, 
N = 6). CsA (1 and ]0#M) had no effect on this 
GTP[yS] formation (data not shown). 
We also studied the effect of CsA on physical 
properties of HL-60 membranes using steady- 
state polarization and differential polarized phase 
fluorometry with 1,6-diphenylhexa- 1,3,5-triene 
probe [20]. We assessed limiting anisotropy and 
rotational correlation time. Limiting anisotropy in 
HL-60 membranes treated with solvent (control) 
was l).175-+ 0.002, and rotational correlation time 
was 1.445 -+ 0.106 nsec (means -+ SD. N = 3). CsA 
(1 #M) did not change these values (data not shown). 
Finally, we studied the effects of CsA on the 
activity of Mge+-ATPase and Na+/K+-ATPase in 
HL-60 membranes. The activity of these enzymes 
was0.25 -+ 0.03/xmol/mg/min a d0. t4 -+ 0.01/zmol/ 
mg/min, respectively (means +- SD, N = 4). CsA (1, 
3 and 10/~M) had no effect on Mg2+-ATPase and 
Na+/K+-ATPase (data not shown). 
DISCUSSION 
In agreement with the data obtained with human 
neutrophils and murine peritoneal macrophages 
[9-11], we found that CsA inhibits phorbol ester- 
induced 02 formation in HL-60 cells (see Figs 1 and 
2). We tested various hypotheses in an attempt o 
explain these effects of CsA. 
PMA- and formyl peptide-mediated 02 formation 
involves activation of n-PKC isoenzymes [7], and 
CsA inhibits 02 formation induced by both stimuli 
(see Figs 1 and 2) [9-12]. From these findings, the 
question arises as to whether CsA inhibits these 
PKC isoenzymes. Due to the fact that purification 
to homogeneity of n-PKC isoenzymes from tissues 
or cells is difficult to perform, we used recombinant 
n-PKC isoenzymes. Unlike G6 6850, CsA had no 
effect on two n-PKC isoenzymes (see Table 1). 
Additionally, CsA did not inhibit a recombinant a- 
PKC isoenzyme (see Table 1). Furthermore, and in 
close agreement with the data obtained by Szamel 
et al. [14] who studied human lymphocytes, we could 
not detect an inhibitory effect of CsA on c-PKC 
isoenzymes, regardless of whether recombinant 
enzymes or enzymes purified from rat brain were 
used (see Table 1). Moreover, CsA failed to revert 
PMA-mediated inhibition of agonist-induced rises in 
[Ca2+]i in HL-60 cells, PMA-mediated ifferentiation 
of these cells, PMA-mediated platelet aggregation 
or various effects of PMA in human lymphocytes 
[14]. All these data render it unlikely that PMA 
inhibits 0 2 formation through direct inhibition of a 
known PKC isoenzyme. 
Thus, does CsA interfere with a component 
specifically involved in NADPH oxidase activation? 
A candidate in this regard is NDPK which catalyses 
thiophosphorylation f GDP to GTP[FS], ATP[vS] 
being the thiophosphoryl group donor [19]. The 
newly formed GTP[yS] then potentiates 02 
formation through activation of GTP-binding 
proteins [19]. However, CsA does not interfere with 
NDPK. Previous studies have already shown that 
CsA is not a formyl peptide receptor antagonist and 
does not interfere with GTP-binding proteins or the 
mechanisms leading to rises in [Cae+]i [9, 10, 12]. 
Moreover, CsA does not inhibit the catalytic domain 
of NADPH oxidase and does not scavenge 02 or 
inhibit glucose transport or energy metabolism 
[9, 10]. 
Inhibition of superoxide anion formation by cyclosporin A
CsA interacts with phospholipid bilayers and has 
been shown to alter the physical properties of 
lymphocyte membranes [29, 30]. In addition, it has 
been reported to inhibit NA+/K+-ATPase,  a 
membrane-bound enzyme which is sensitive to 
changes in physical membrane state [31], in 
lymphocytes [32]. These findings raise the question 
of whether CsA inhibits 02  formation through 
alterations in physical membrane properties. 
However,  CsA did not affect limiting anisotropy (a 
static measure) [20] and rotational correlation time 
(a dynamic measure) [20] of a fluorescent probe in 
HL-60 membranes, nor did it affect the activity of 
NA+/K+-ATPase  and MgZ+-ATPase in HE-60 
membranes. These findings render it unlikely that 
CsA inhibits 02  formation through changes in 
physical membrane properties. 
In conclusion, we have shown that CsA inhibits 
phorbol ester-induced 02  formation in HL-60 cells 
but not other phorbol ester-mediated events. 
Inhibition by CsA of O f  formation cannot readily 
be attributed to direct PKC inhibition, interference 
with known components of NADPH oxidase or 
changes in physical membrane properties. Thus, our 
results clearly emphasize the need for additional 
work to elucidate the mechanism by which CsA 
inhibits Of  formation. 
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